Keros Therapeutics financial statements

케로스 테라퓨틱스NASDAQ:KROS · Nasdaq · Healthcare · sector #17
$11.01-4.43%
2026-10-06 close

Keros Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $4M. 2024 operating profit was −$211M.

Reported results

Keros Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q